Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study

Diabetes Care. 2013 Nov;36(11):3663-70. doi: 10.2337/dc13-0382. Epub 2013 Sep 5.

Abstract

Objective: Inflammatory processes have been implicated in the pathogenesis of diabetic distal sensorimotor polyneuropathy (DSPN), but their possible relationship has not been assessed at the population level.

Research design and methods: We determined serum concentrations of mediators of subclinical inflammation among 1,047 participants 61-82 years of age from the population-based Cooperative Health Research in the Region of Augsburg (KORA) F4 study (Germany). Logistic and linear regression models were fitted to assess associations between immune mediators (log-transformed) and the presence of clinical DSPN (dichotomous variable) or Michigan Neuropathy Screening Instrument (MNSI) examination score (continuous variable), respectively.

Results: Serum concentrations of the anti-inflammatory interleukin (IL)-1 receptor antagonist (IL-1RA) were positively associated with the presence of DSPN and higher MNSI scores in age-adjusted and sex-adjusted analyses, whereas IL-6, IL-18, and soluble intercellular adhesion molecule-1 were positively associated with only MNSI scores. No associations were observed for adiponectin, C-reactive protein, or tumor necrosis factor-α. Associations for IL-1RA and IL-6 with the MNSI score remained statistically significant after additional adjustment for waist circumference, height, hypertension, cholesterol, smoking, alcohol intake, physical activity, history of myocardial infarction or stroke, presence of neurological conditions, and use of nonsteroidal anti-inflammatory drugs.

Conclusions: We conclude that DSPN is linked to proinflammatory and anti-inflammatory, possibly compensatory, processes in the older general population. Future studies should clarify the temporal sequence and causality of these associations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • C-Reactive Protein / analysis
  • Diabetic Neuropathies / blood
  • Diabetic Neuropathies / drug therapy
  • Diabetic Neuropathies / epidemiology*
  • Female
  • Germany / epidemiology
  • Humans
  • Inflammation / blood
  • Inflammation Mediators / blood*
  • Intercellular Adhesion Molecule-1 / blood
  • Interleukin 1 Receptor Antagonist Protein / blood
  • Interleukin-18 / blood
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Polyneuropathies / blood
  • Polyneuropathies / drug therapy
  • Polyneuropathies / epidemiology*
  • Tumor Necrosis Factor-alpha / blood
  • Waist Circumference

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Inflammation Mediators
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-18
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • C-Reactive Protein